Rapid Micro Biosystems Inc - Asset Resilience Ratio
Rapid Micro Biosystems Inc (RPID) has an Asset Resilience Ratio of 24.40% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Rapid Micro Biosystems Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Rapid Micro Biosystems Inc's Asset Resilience Ratio has changed over time. See Rapid Micro Biosystems Inc shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Rapid Micro Biosystems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Rapid Micro Biosystems Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $18.27 Million | 24.4% |
| Total Liquid Assets | $18.27 Million | 24.40% |
Asset Resilience Insights
- Good Liquidity Position: Rapid Micro Biosystems Inc maintains a healthy 24.40% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Rapid Micro Biosystems Inc Industry Peers by Asset Resilience Ratio
Compare Rapid Micro Biosystems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Rapid Micro Biosystems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 24.40% | $18.27 Million | $74.85 Million | -10.05pp |
| 2024-12-31 | 34.45% | $33.82 Million | $98.17 Million | -12.79pp |
| 2023-12-31 | 47.24% | $67.77 Million | $143.45 Million | +4.45pp |
| 2022-12-31 | 42.79% | $81.58 Million | $190.65 Million | +36.53pp |
| 2021-12-31 | 6.27% | $15.11 Million | $241.17 Million | -15.16pp |
| 2020-12-31 | 21.43% | $15.00 Million | $70.00 Million | +20.97pp |
| 2019-12-31 | 0.46% | $146.00K | $31.69 Million | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more